Skip to main content
OpenTrials

Clinical trial condition

Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)

Explore clinical trials studying Vulvar High Grade Squamous Intraepithelial Lesion (HSIL). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) trial results

Completed

Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)

NCT03180684

Conditions
Human Papillomavirus (HPV), Pre-cancerous Lesions of the Vulva, VIN2, +4 more
Locations
  • Christiana Care Health Systems Newark, Delaware, United States
  • Augusta University Augusta, Georgia, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Maine Medical Center Scarborough, Maine, United States
View all 15 locations
View Trial Details

Related conditions